Literature DB >> 27924526

The p. R151C Polymorphism in MC1R Gene Modifies the Age of Onset in Spanish Huntington's Disease Patients.

Gemma Tell-Marti1,2, Joan Anton Puig-Butille2,3, Pol Gimenez-Xavier1,2, Ariadna Segu-Roig1, Miriam Potrony1, Celia Badenas2,3, Victoria Alvarez4, José M Millán2,5, María José Trujillo-Tiebas2,6, María A Ramos-Arroyo7, Montserrat Milà2,3, Susana Puig8,9,10.   

Abstract

The expansion of CAG repeats (≥36 CAG) in the HTT gene is the only known genetic cause of Huntington's disease (HD) and the main determinant of the course of the disease. The length of the expanded CAG repeats correlates inversely with the age of onset (AOO) but does not completely determine it. We investigated the role of the melanocortin 1 receptor (MC1R) gene as a modifier factor of AOO in 600 HD patients from Spain. We sequenced the entire region of the MC1R gene and analyzed all the nonsynonymous MC1R genetic variants with a minor allele frequency of at least 0.01 in HD patients. The variability in AOO attributable to the CAG repeats and MC1R polymorphisms was evaluated using a multiple linear regression model. We found that the loss-of-function p. R151C MC1R polymorphism has a significant influence on the AOO (P = 0.004; Bonferroni-corrected P = 0.032) which explains 1.42% of the variance in AOO that cannot be accounted for by the expanded CAG repeat. Our results suggest that the MC1R gene could modify the AOO in Spanish HD patients and encourage the evaluation of loss-of-function MC1R polymorphisms in other HD populations with a higher frequency of these MC1R polymorphisms.

Entities:  

Keywords:  Age of onset; Huntington’s disease; Melanocortin 1 receptor (MC1R) gene; Neurodegenerative diseases; p. R151C

Mesh:

Substances:

Year:  2016        PMID: 27924526     DOI: 10.1007/s12035-016-0305-5

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  22 in total

1.  The S18Y polymorphism in the UCHL1 gene is a genetic modifier in Huntington's disease.

Authors:  Silke Metzger; Peter Bauer; Juergen Tomiuk; Franco Laccone; Stefano Didonato; Cinzia Gellera; Paola Soliveri; Herwig W Lange; Helga Weirich-Schwaiger; Gregor K Wenning; Bela Melegh; Victoria Havasi; Lazlo Balikó; Stefan Wieczorek; Larissa Arning; Jacek Zaremba; Anna Sulek; Dorota Hoffman-Zacharska; A Nazli Basak; Nagehan Ersoy; Jana Zidovska; Vera Kebrdlova; Massimo Pandolfo; Pascale Ribaï; Ludovit Kadasi; Marta Kvasnicova; Bernhard H F Weber; Friedmar Kreuz; Matthias Dose; Manfred Stuhrmann; Olaf Riess
Journal:  Neurogenetics       Date:  2005-12-21       Impact factor: 2.660

2.  MC1R gene variants and sporadic malignant melanoma susceptibility in the Canary Islands population.

Authors:  Elizabeth Córdoba-Lanús; José G Hernández-Jiménez; Chaxiraxi Medina-Coello; Adriana Espinoza-Jiménez; Ana González; María-Del-Cristo Rodríguez-Pérez; Gregorio Carretero-Hernández; Pablo Almeida; José Suárez-Hernández; Antonio Perera-Molinero; Ricardo Fernández-de-Misa
Journal:  Arch Dermatol Res       Date:  2013-10-30       Impact factor: 3.017

Review 3.  Oxidative stress in Huntington's disease.

Authors:  S E Browne; R J Ferrante; M F Beal
Journal:  Brain Pathol       Date:  1999-01       Impact factor: 6.508

Review 4.  Melanocortins and the melanocortin 1 receptor, moving translationally towards melanoma prevention.

Authors:  Zalfa A Abdel-Malek; Viki B Swope; Renny J Starner; Leonid Koikov; Pamela Cassidy; Sancy Leachman
Journal:  Arch Biochem Biophys       Date:  2014-07-11       Impact factor: 4.013

5.  Melanocortin receptor 1 variants and melanoma risk: a study of 2 European populations.

Authors:  Dominique Scherer; Eduardo Nagore; Justo Lorenzo Bermejo; Adina Figl; Rafael Botella-Estrada; Ranjit Kumar Thirumaran; Sabrina Angelini; Kari Hemminki; Dirk Schadendorf; Rajiv Kumar
Journal:  Int J Cancer       Date:  2009-10-15       Impact factor: 7.396

Review 6.  Neuroprotective actions of melanocortins: a therapeutic opportunity.

Authors:  Anna Catania
Journal:  Trends Neurosci       Date:  2008-06-10       Impact factor: 13.837

7.  Genetic determinants of hair color and Parkinson's disease risk.

Authors:  Xiang Gao; Kelly C Simon; Jiali Han; Michael A Schwarzschild; Alberto Ascherio
Journal:  Ann Neurol       Date:  2009-01       Impact factor: 10.422

8.  Mismatch repair genes Mlh1 and Mlh3 modify CAG instability in Huntington's disease mice: genome-wide and candidate approaches.

Authors:  Ricardo Mouro Pinto; Ella Dragileva; Andrew Kirby; Alejandro Lloret; Edith Lopez; Jason St Claire; Gagan B Panigrahi; Caixia Hou; Kim Holloway; Tammy Gillis; Jolene R Guide; Paula E Cohen; Guo-Min Li; Christopher E Pearson; Mark J Daly; Vanessa C Wheeler
Journal:  PLoS Genet       Date:  2013-10-31       Impact factor: 5.917

9.  An ultraviolet-radiation-independent pathway to melanoma carcinogenesis in the red hair/fair skin background.

Authors:  Devarati Mitra; Xi Luo; Ann Morgan; Jin Wang; Mai P Hoang; Jennifer Lo; Candace R Guerrero; Jochen K Lennerz; Martin C Mihm; Jennifer A Wargo; Kathleen C Robinson; Suprabha P Devi; Jillian C Vanover; John A D'Orazio; Martin McMahon; Marcus W Bosenberg; Kevin M Haigis; Daniel A Haber; Yinsheng Wang; David E Fisher
Journal:  Nature       Date:  2012-10-31       Impact factor: 49.962

10.  Capturing the biological impact of CDKN2A and MC1R genes as an early predisposing event in melanoma and non melanoma skin cancer.

Authors:  Joan Anton Puig-Butille; María José Escámez; Francisco Garcia-Garcia; Gemma Tell-Marti; Àngels Fabra; Lucía Martínez-Santamaría; Celia Badenas; Paula Aguilera; Marta Pevida; Joaquín Dopazo; Marcela del Río; Susana Puig
Journal:  Oncotarget       Date:  2014-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.